[Intense pulsed light (IPL) as a therapeutic option for Meibomian gland dysfunction]

A Schuh1, S Priglinger2, E M Messmer2

  • 1Augenklinik, Klinikum der Universität München, Campus Innenstadt, Mathildenstr. 8, 80336, München, Deutschland. anna.schuh@med.uni-muenchen.de.

Summary

Intense pulsed light (IPL) therapy offers a safe and effective new treatment for Meibomian gland dysfunction (MGD), a common cause of dry eye disease. Studies show IPL improves both patient-reported symptoms and clinical signs of MGD.